Latest News & Features
Refine Search
Americas
Canada-based Bausch Health has agreed to settle its dispute with generic maker Sandoz over the latter’s attempt to release a generic version of antibiotic Xifaxan. 7 May 2020
Americas
Criminal investigators in the US Homeland Security Investigations’ National Intellectual Property Rights Coordination Center have partnered with Pfizer, 3M, Citi, Alibaba, Amazon and Merck & Co to combat fraud and other illegal activity related to COVID-19. 6 May 2020
Americas
US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic. 5 May 2020
Asia-Pacific
An Australian federal judge has thrown out a challenge by Gilead Sciences to the wording of infringement claims made by a GlaxoSmithKline subsidiary. 5 May 2020
Americas
3M has filed four more trademark lawsuits against companies accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic, while also securing a preliminary injunction in another suit. 5 May 2020
Big Pharma
Once a genuine vaccine against COVID-19 has been announced, counterfeiters and fraudsters are likely to invest heavily in offering ineffective counterfeit versions of the vaccine online, according to Europol. 1 May 2020
Biotechnology
The University of Oxford has partnered with UK pharmaceutical company AstraZeneca to develop and manufacture the university’s trial COVID-19 vaccine. 30 April 2020
Big Pharma
The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates. 30 April 2020
Big Pharma
Gilead has escalated its dispute with the US federal government by filing a new lawsuit accusing it of improperly filing for patents covering HIV drug Truvada. 29 April 2020
Americas
3M has filed another trademark infringement suit against what it’s called a “deplorable pandemic profiteer”, as the multinational seeks to stop the alleged price-gouging of N95 masks amid the COVID-19 outbreak. 29 April 2020